Document is current
Any future updates will be listed below
-
Authors
Yu, Lei https://orcid.org/0000-0002-1610-9479
Wang, Yajie
Liu, Yuanchen
Xing, Xiaomin https://orcid.org/0009-0003-2933-0003
Li, Chen
Wang, Xun
Shi, Jialu
Ma, Wentai https://orcid.org/0000-0003-1931-8687
Li, Jiayan
Chen, Yanjia
Qiao, Rui
Zhao, Xiaoyu https://orcid.org/0000-0002-0347-9104
Tian, Shilei
Gao, Ming
Wen, Shuhua
Xue, Yingxue
Qiu, Tianyi
Yu, Hongjie https://orcid.org/0000-0002-6335-5648
Guan, Yongjun https://orcid.org/0000-0001-6546-2095
Chu, Hin https://orcid.org/0000-0003-2855-9837
Sun, Lei https://orcid.org/0000-0001-8741-0202
Wang, Pengfei https://orcid.org/0000-0003-2454-7652
- License Information
-
More Information
Article History
Received: 19 July 2024
Accepted: 18 February 2025
First Online: 6 March 2025
Competing interests
: Y.G. is a co-founder and shareholder of Antibody BioPharm, Inc. and ChangYuan FuNeng (Shanghai) Life Technology Co., Ltd. The remaining authors declare no competing interests.
